Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.

Safety and antigenicity of a purified preparation of Salmonella typhosa Vi antigen was evaluated in human volunteers. Dosages of Vi antigen at 25, 50, and 100 mug were less toxic than U.S. standard typhoid vaccine (lot 6A) containing 5 X 10(8) bacteria per dosage. Vi antigen in comparison with the s...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Infect Immun
Autori principali:	Levin, D M, Wong, K H, Reynolds, H Y, Sutton, A, Northrup, R S
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1975
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415434/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/54336/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.12.6.1290-1294.1975
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!